Advertising majors are strengthening their healthcare wings to woo pharma clients. Initially, Lin Health, the healthcare wing of Lowe India, is planing to bring in fresh talent to strengthen its offerings. RK Swamy BBDO’s healthcare wing Pharma Direction too is adding man power to handle new clients. Yet another ad major, DDB Health Care & Lifestyle, healthcare wing of Mudra Group, is chalking out a three-pronged strategy to sustain the growth momentum.
Publicis Healthcare Communications Group (PHCG) has forayed into the Indian advertising industry with the launch of Saatchi & Saatchi Health. At present, Lin Health’s clientele includes Abbots, GSK, Ranbaxy and Piramal HealthCare, among others. Across the road, RK Swamy BBDO’s Pharma Direction is adding manpower in its existing team in Bangalore, Mumbai and New Delhi.
According to the ‘Pharmaceutical Drug Manufacturers’ report, India is the third largest producer of pharmaceuticals in the world and is already a $8.2 billion pharmaceutical market, with growth expectations of 10-14% per year. IMS Health predicts India will add $5-15 billion to the pharmaceutical market through 2013.